Vortioxetine inhibited gastric cancer cell growth by reducing the kinase activity of JAK2 and Src [147], but other data, while confirming growth inhibition, indicated that the inhibition of gastric cancer cell growth by vortioxetine involved PI3K/AKT [148]. The gene discussed is SRC; the disease is gastric cancer.